FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220943697> ?p ?o ?g. }

• W4220943697 endingPage "e1747" @default.
• W4220943697 startingPage "e1738" @default.
• W4220943697 abstract "Background and Objectives Chronic kidney disease is a worldwide public health problem that is recognized as an established risk factor for stroke. It remains unclear whether its distribution and clinical impact are consistent across ischemic stroke subtypes in patients with renal impairment. We examined whether renal impairment was associated with the proportion of each stroke subtype vs ischemic stroke overall and with functional outcomes after each stroke subtype. Methods Study participants were 10,392 adult patients with an acute stroke from the register of the Japan Stroke Data Bank, a hospital-based multicenter stroke registration database, between October 2016 and December 2019, whose baseline serum creatinine levels or a dipstick proteinuria result were available. All ischemic strokes were classified according to the Trial of Org 10172 in Acute Stroke Treatment criteria. Unfavorable functional outcome was defined as modified Rankin Scale (mRS) score 3–6 at discharge. Mixed effect logistic regression was used to determine the relationship between the outcomes and the estimated glomerular filtration rate (eGFR), eGFR strata (<45, 45–59, ≥60 mL/min/1.73 m 2 ), or dipstick proteinuria ≥1 adjusted for covariates. Results Overall, 2,419 (23%) patients had eGFR 45–59 mL/min/1.73 m 2 and 1,976 (19%) had eGFR <45 mL/min/1.73 m 2 , including 185 patients (1.8%) receiving hemodialysis. Both eGFR 45–59 and eGFR <45 mL/min/1.73 m 2 were associated with a higher proportion of cardioembolic stroke (odds ratio [OR], 1.21 [95% CI, 1.05–1.39] and 1.55 [1.34–1.79], respectively) and a lower proportion of small vessel occlusion (0.79 [0.69–0.90] and 0.68 [0.59–0.79], respectively). A similar association with the proportion of these 2 subtypes was proven in the analyses using decreased eGFR as continuous values. Both eGFR <45 mL/min/1.73 m 2 and proteinuria were associated with unfavorable functional outcomes in patients with cardioembolic stroke (OR, 1.30 [95% CI, 1.01–1.69] and 3.18 [2.03–4.98], respectively) and small vessel occlusion (OR, 1.44 [1.01–2.07] and 2.08 [1.08–3.98], respectively). Discussion Renal impairment contributes to the different distributions and clinical effects across specific stroke subtypes, particularly evident in cardioembolic stroke and small vessel occlusion. This possibly indicates shared mechanisms of susceptibility and potentially enhancing pathways." @default.
• W4220943697 created "2022-04-03" @default.
• W4220943697 creator A5013790464 @default.
• W4220943697 creator A5018515174 @default.
• W4220943697 creator A5029496020 @default.
• W4220943697 creator A5035717519 @default.
• W4220943697 creator A5042534277 @default.
• W4220943697 creator A5044924284 @default.
• W4220943697 creator A5046856057 @default.
• W4220943697 creator A5053036137 @default.
• W4220943697 creator A5064352051 @default.
• W4220943697 creator A5069400219 @default.
• W4220943697 creator A5072418444 @default.
• W4220943697 creator A5087915688 @default.
• W4220943697 creator A5089174689 @default.
• W4220943697 date "2022-03-08" @default.
• W4220943697 modified "2023-09-30" @default.
• W4220943697 title "Etiology and Outcome of Ischemic Stroke in Patients With Renal Impairment Including Chronic Kidney Disease" @default.
• W4220943697 cites W1570583414 @default.
• W4220943697 cites W1592462907 @default.
• W4220943697 cites W2004354281 @default.
• W4220943697 cites W2009876331 @default.
• W4220943697 cites W2031100777 @default.
• W4220943697 cites W2035799712 @default.
• W4220943697 cites W2051452106 @default.
• W4220943697 cites W2054077136 @default.
• W4220943697 cites W2067395123 @default.
• W4220943697 cites W2068568996 @default.
• W4220943697 cites W2070975253 @default.
• W4220943697 cites W2072569564 @default.
• W4220943697 cites W2085743961 @default.
• W4220943697 cites W2102999261 @default.
• W4220943697 cites W2138595885 @default.
• W4220943697 cites W2152189242 @default.
• W4220943697 cites W2161569030 @default.
• W4220943697 cites W2335631045 @default.
• W4220943697 cites W2467227824 @default.
• W4220943697 cites W2475261460 @default.
• W4220943697 cites W2566840215 @default.
• W4220943697 cites W2683396644 @default.
• W4220943697 cites W2773904775 @default.
• W4220943697 cites W2791383098 @default.
• W4220943697 cites W2794029240 @default.
• W4220943697 cites W2794103777 @default.
• W4220943697 cites W2883898882 @default.
• W4220943697 cites W2889431295 @default.
• W4220943697 cites W2900120236 @default.
• W4220943697 cites W2913869981 @default.
• W4220943697 cites W2918092070 @default.
• W4220943697 cites W2953615740 @default.
• W4220943697 cites W2974939447 @default.
• W4220943697 cites W2980622701 @default.
• W4220943697 cites W3000359955 @default.
• W4220943697 cites W3005957464 @default.
• W4220943697 cites W3021956429 @default.
• W4220943697 cites W3026946252 @default.
• W4220943697 cites W3058611675 @default.
• W4220943697 cites W3164065046 @default.
• W4220943697 cites W3169424521 @default.
• W4220943697 doi "https://doi.org/10.1212/wnl.0000000000200153" @default.
• W4220943697 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35260440" @default.
• W4220943697 hasPublicationYear "2022" @default.
• W4220943697 type Work @default.
• W4220943697 citedByCount "12" @default.
• W4220943697 countsByYear W42209436972022 @default.
• W4220943697 countsByYear W42209436972023 @default.
• W4220943697 crossrefType "journal-article" @default.
• W4220943697 hasAuthorship W4220943697A5013790464 @default.
• W4220943697 hasAuthorship W4220943697A5018515174 @default.
• W4220943697 hasAuthorship W4220943697A5029496020 @default.
• W4220943697 hasAuthorship W4220943697A5035717519 @default.
• W4220943697 hasAuthorship W4220943697A5042534277 @default.
• W4220943697 hasAuthorship W4220943697A5044924284 @default.
• W4220943697 hasAuthorship W4220943697A5046856057 @default.
• W4220943697 hasAuthorship W4220943697A5053036137 @default.
• W4220943697 hasAuthorship W4220943697A5064352051 @default.
• W4220943697 hasAuthorship W4220943697A5069400219 @default.
• W4220943697 hasAuthorship W4220943697A5072418444 @default.
• W4220943697 hasAuthorship W4220943697A5087915688 @default.
• W4220943697 hasAuthorship W4220943697A5089174689 @default.
• W4220943697 hasBestOaLocation W42209436971 @default.
• W4220943697 hasConcept C126322002 @default.
• W4220943697 hasConcept C127413603 @default.
• W4220943697 hasConcept C156957248 @default.
• W4220943697 hasConcept C159641895 @default.
• W4220943697 hasConcept C2778653478 @default.
• W4220943697 hasConcept C2779561371 @default.
• W4220943697 hasConcept C2780091579 @default.
• W4220943697 hasConcept C2780645631 @default.
• W4220943697 hasConcept C2780931571 @default.
• W4220943697 hasConcept C3020199598 @default.
• W4220943697 hasConcept C541997718 @default.
• W4220943697 hasConcept C71924100 @default.
• W4220943697 hasConcept C78519656 @default.
• W4220943697 hasConceptScore W4220943697C126322002 @default.
• W4220943697 hasConceptScore W4220943697C127413603 @default.
• W4220943697 hasConceptScore W4220943697C156957248 @default.
• W4220943697 hasConceptScore W4220943697C159641895 @default.

• next